Georgia Tech has achieved its most successful year in research commercialization, setting new records for invention disclosures, issued patents, and licensed technologies. The Institute’s leadership highlights these results as evidence of its increasing impact in bringing research-driven innovation to the market.
“Invention is only the beginning. What sets Georgia Tech apart is our ability to move our ideas out of the lab and into the marketplace, where they can make a tangible impact on human life and contribute to our economy,” said Ángel Cabrera, president of Georgia Tech. “This year’s record results show that our researchers aren’t just pushing the boundaries of knowledge — they’re creating marketable solutions with the power to improve everyday lives.”
The Institute reports that this momentum strengthens Atlanta’s position among rapidly growing innovation economies in the United States. Georgia Tech continues to connect academic research with industry needs, supporting startups and talent development in sectors such as artificial intelligence, cybersecurity, and clean energy.
Omer Inan, a faculty member at Georgia Tech, has started several companies utilizing support from the school’s commercialization programs. His company Cardiosense recently received FDA 501(k) clearance for CardioTag, a wearable sensor device designed to monitor heart health by capturing multiple cardiovascular signals simultaneously.
“The med tech research I conduct at Georgia Tech delivers new technologies to keep patients with heart failure out of the hospital and enables them to monitor their health status at home,” said Inan. “Now, we are commercializing the technology our lab helped develop, so that this dream of improving the quality of care and life for millions of Americans with heart failure can one day become reality.”
Raghupathy “Siva” Sivakumar, vice president of Commercialization at Georgia Tech, emphasized efforts to move more research innovations into practical use. “As we look to solidify Georgia Tech’s status as a national innovation hub, we are moving research into the marketplace so it can truly make a difference in people’s lives,” Sivakumar said. “We are at a pivotal moment to put Atlanta on the map as a leader in research commercialization and have an opportunity to capitalize on our $1.4 billion in research expenditures that drive meaningful inventions, IP, and industry partnerships.”
More information about licensing and commercialization at Georgia Tech is available at https://licensing.research.gatech.edu/.
